These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 32908944)

  • 41. Comparison of penicillins (penicillin G and ampicillin) and cefazolin as a definitive therapy against penicillin-susceptible Staphylococcus aureus (PSSA) bacteremia in Japan: a retrospective cohort study.
    Moriyama Y; Ishikane M; Mezaki K; Ohmagari N
    J Infect Chemother; 2020 Apr; 26(4):358-362. PubMed ID: 31822451
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Nafcillin versus cefazolin for the treatment of methicillin-susceptible Staphylococcus aureus bacteremia.
    Monogue ML; Ortwine JK; Wei W; Eljaaly K; Bhavan KP
    J Infect Public Health; 2018; 11(5):727-731. PubMed ID: 29526442
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Antistaphylococcal Penicillin vs Cefazolin for the Treatment of Methicillin-Susceptible
    Corsini Campioli C; Go JR; Abu Saleh O; Challener D; Yetmar Z; Osmon DR
    Open Forum Infect Dis; 2021 Mar; 8(3):ofab071. PubMed ID: 33738321
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A large retrospective cohort study of cefazolin compared with flucloxacillin for methicillin-susceptible Staphylococcus aureus bacteraemia.
    Davis JS; Turnidge J; Tong S
    Int J Antimicrob Agents; 2018 Aug; 52(2):297-300. PubMed ID: 29499317
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Multifaceted antibiotic treatment analysis of methicillin-sensitive Staphylococcus aureus bloodstream infections.
    Weber Z; Ariano R; Lagacé-Wiens P; Zelenitsky S
    Int J Antimicrob Agents; 2016 Dec; 48(6):674-679. PubMed ID: 27789207
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The Safety and Economic Impact of Cefazolin versus Nafcillin for the Treatment of Methicillin-Susceptible Staphylococcus aureus Bloodstream Infections.
    Flynt LK; Kenney RM; Zervos MJ; Davis SL
    Infect Dis Ther; 2017 Jun; 6(2):225-231. PubMed ID: 28265972
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Oritavancin vs Standard of Care for Treatment of Nonendovascular Gram-Positive Bloodstream Infections.
    Moenster RP; Wallace-Lacey A; Western H; Tiefenaur S; Abdulbasir A; Alberts J; Doty J; Abner H; Skouby D; Lorenz M; Fong R; Arora J; Linneman TW
    Open Forum Infect Dis; 2023 Nov; 10(11):ofad411. PubMed ID: 37937043
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comparative outcomes of cefazolin versus nafcillin for methicillin-susceptible Staphylococcus aureus bacteraemia: a prospective multicentre cohort study in Korea.
    Lee S; Song KH; Jung SI; Park WB; Lee SH; Kim YS; Kwak YG; Kim YK; Kiem SM; Kim HI; Kim ES; Park KH; Kim NJ; Jang HC; Kim HB;
    Clin Microbiol Infect; 2018 Feb; 24(2):152-158. PubMed ID: 28694202
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cefazolin vs. anti-staphylococcal penicillins for treatment of methicillin-susceptible Staphylococcus aureus bloodstream infections in acutely ill adult patients: Results of a systematic review and meta-analysis.
    Lee BJ; Wang SK; Constantino-Corpuz JK; Apolinario K; Nadler B; McDanel JS; Scheetz MH; Rhodes NJ
    Int J Antimicrob Agents; 2019 Mar; 53(3):225-233. PubMed ID: 30476572
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The Cefazolin Inoculum Effect Is Associated With Increased Mortality in Methicillin-Susceptible
    Miller WR; Seas C; Carvajal LP; Diaz L; Echeverri AM; Ferro C; Rios R; Porras P; Luna C; Gotuzzo E; Munita JM; Nannini E; Carcamo C; Reyes J; Arias CA
    Open Forum Infect Dis; 2018 Jun; 5(6):ofy123. PubMed ID: 29977970
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Is cefazolin inferior to nafcillin for treatment of methicillin-susceptible Staphylococcus aureus bacteremia?
    Lee S; Choe PG; Song KH; Park SW; Kim HB; Kim NJ; Kim EC; Park WB; Oh MD
    Antimicrob Agents Chemother; 2011 Nov; 55(11):5122-6. PubMed ID: 21825299
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cefazolin versus cloxacillin as definitive antibiotic therapy for methicillin-susceptible Staphylococcus aureus spinal epidural abscess: a retrospective cohort study.
    Bai AD; Findlater A; Irfan N; Singhal N; Loeb M
    Int J Antimicrob Agents; 2021 Nov; 58(5):106429. PubMed ID: 34469802
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Persistent Methicillin-Susceptible Bacteremia Rapidly Cleared with Cefazolin and Ertapenem Combination Therapy in a Patient with COVID-19.
    Ilges D; Krishnan G; Geng E
    Case Rep Infect Dis; 2022; 2022():6828538. PubMed ID: 35462678
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comparative effectiveness of nafcillin or cefazolin versus vancomycin in methicillin-susceptible Staphylococcus aureus bacteremia.
    Schweizer ML; Furuno JP; Harris AD; Johnson JK; Shardell MD; McGregor JC; Thom KA; Cosgrove SE; Sakoulas G; Perencevich EN
    BMC Infect Dis; 2011 Oct; 11():279. PubMed ID: 22011388
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Are there differences in hospital cost between patients with nosocomial methicillin-resistant Staphylococcus aureus bloodstream infection and those with methicillin-susceptible S. aureus bloodstream infection?
    Ben-David D; Novikov I; Mermel LA
    Infect Control Hosp Epidemiol; 2009 May; 30(5):453-60. PubMed ID: 19344266
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Treatment of methicillin-sensitive Staphylococcus aureus bacteremia secondary to septic phlebitis using dalbavancin.
    Cho JC; Estrada SJ; Beltran AJ; Revuelta MP
    J Clin Pharm Ther; 2015 Oct; 40(5):604-606. PubMed ID: 26183753
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Meta-analysis of trials comparing cefazolin to antistaphylococcal penicillins in the treatment of methicillin-sensitive Staphylococcus aureus bacteraemia.
    Rindone JP; Mellen CK
    Br J Clin Pharmacol; 2018 Jun; 84(6):1258-1266. PubMed ID: 29600576
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Clindamycin Efficacy in Patients With Methicillin-Sensitive Staphylococcus aureus in a Fourth-Level Hospital in the City of Medellín.
    Alvarez-Payares JC; Palacios M JE; De la Peña E; Cabrera HB; Giraldo-Ramírez S; Loaiza M; Jaimes F; Rodelo J; Ágamez-Gómez J
    Cureus; 2022 Jan; 14(1):e21124. PubMed ID: 35036237
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Haematological and hepatic adverse effects of ceftriaxone in ambulatory care: a dual-centre retrospective observational analysis of standard vs high dose.
    Mistry R; Rawson TM; Troise O; Mughal N; Moore LSP; Hughes S
    BMC Infect Dis; 2022 Dec; 22(1):959. PubMed ID: 36566229
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Use of vancomycin or first-generation cephalosporins for the treatment of hemodialysis-dependent patients with methicillin-susceptible Staphylococcus aureus bacteremia.
    Stryjewski ME; Szczech LA; Benjamin DK; Inrig JK; Kanafani ZA; Engemann JJ; Chu VH; Joyce MJ; Reller LB; Corey GR; Fowler VG
    Clin Infect Dis; 2007 Jan; 44(2):190-6. PubMed ID: 17173215
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.